State of Alaska Department of Revenue Decreases Stock Position in CVS Health Corporation $CVS

State of Alaska Department of Revenue trimmed its holdings in shares of CVS Health Corporation (NYSE:CVS) by 4.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 169,139 shares of the pharmacy operator’s stock after selling 7,159 shares during the period. State of Alaska Department of Revenue’s holdings in CVS Health were worth $12,751,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CVS. Avion Wealth boosted its position in shares of CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares during the last quarter. Harbor Capital Advisors Inc. boosted its holdings in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 142 shares during the last quarter. Harbor Asset Planning Inc. bought a new stake in shares of CVS Health in the second quarter worth approximately $30,000. Front Row Advisors LLC raised its holdings in shares of CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares during the last quarter. Finally, Roxbury Financial LLC lifted its position in CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the period. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Down 0.4%

NYSE CVS opened at $80.29 on Friday. CVS Health Corporation has a 52 week low of $46.34 and a 52 week high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $101.92 billion, a P/E ratio of 211.29, a price-to-earnings-growth ratio of 0.74 and a beta of 0.48. The stock’s 50-day moving average price is $78.70 and its 200-day moving average price is $73.83.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same period in the prior year, the firm posted $1.09 EPS. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.3%. The ex-dividend date is Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on CVS shares. Truist Financial set a $100.00 target price on shares of CVS Health in a research note on Wednesday, December 10th. Argus upped their price objective on CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. Wells Fargo & Company reduced their price target on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. Finally, Evercore ISI raised their price objective on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $94.86.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.